Financial Management Professionals’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $112K | Buy |
4,666
+107
| +2% | +$2.8K | 0.01% | 215 |
|
|
2026
Q1 | $128K | Buy |
4,559
+896
| +24% | +$23.9K | 0.01% | 181 |
|
|
2025
Q4 | $91.2K | Buy |
3,663
+89
| +2% | +$2.24K | 0.01% | 206 |
|
|
2025
Q3 | $91.1K | Sell |
3,574
-112
| -3% | -$2.76K | 0.01% | 209 |
|
|
2025
Q2 | $89.3K | Sell |
3,686
-557
| -13% | -$13K | 0.01% | 203 |
|
|
2025
Q1 | $108K | Buy |
4,243
+375
| +10% | +$9.81K | 0.01% | 182 |
|
|
2024
Q4 | $103K | Buy |
3,868
+207
| +6% | +$5.62K | 0.01% | 191 |
|
|
2024
Q3 | $106K | Sell |
3,661
-16,939
| -82% | -$494K | 0.01% | 189 |
|
|
2024
Q2 | $576K | Buy |
20,600
+1,511
| +8% | +$41.6K | 0.08% | 78 |
|
|
2024
Q1 | $530K | Buy |
19,089
+2,000
| +12% | +$55.5K | 0.08% | 85 |
|
|
2023
Q4 | $492K | Buy |
17,089
+3,043
| +22% | +$92K | 0.08% | 74 |
|
|
2023
Q3 | $466K | Sell |
14,046
-2,225
| -14% | -$78.7K | 0.08% | 73 |
|
|
2023
Q2 | $597K | Buy |
16,271
+1,305
| +9% | +$50.8K | 0.1% | 62 |
|
|
2023
Q1 | $611K | Buy |
14,966
+3,051
| +26% | +$132K | 0.12% | 60 |
|
|
2022
Q4 | $611K | Buy |
11,915
+2,450
| +26% | +$117K | 0.13% | 52 |
|
|
2022
Q3 | $414K | Sell |
9,465
-633
| -6% | -$30.8K | 0.09% | 59 |
|
|
2022
Q2 | $529K | Buy |
10,098
+516
| +5% | +$26.3K | 0.13% | 55 |
|
|
2022
Q1 | $496K | Buy |
9,582
+618
| +7% | +$32.1K | 0.11% | 60 |
|
|
2021
Q4 | $529K | Buy |
8,964
+57
| +0.6% | +$2.82K | 0.11% | 57 |
|
|
2021
Q3 | $383K | Buy |
8,907
+32
| +0.4% | +$1.42K | 0.09% | 58 |
|
|
2021
Q2 | $348K | Buy |
8,875
+196
| +2% | +$7.62K | 0.09% | 61 |
|
|
2021
Q1 | $314K | Buy |
8,679
+247
| +3% | +$8.77K | 0.08% | 61 |
|
|
2020
Q4 | $310K | Sell |
8,432
-308
| -4% | -$11.3K | 0.09% | 53 |
|
|
2020
Q3 | $304K | Buy |
8,740
+175
| +2% | +$6.14K | 0.11% | 42 |
|
|
2020
Q2 | $266K | Buy |
8,565
+2,342
| +38% | +$79.6K | 0.09% | 45 |
|
|
2020
Q1 | $193K | Sell |
6,223
-64
| -1% | -$2.18K | 0.08% | 46 |
|
|
2019
Q4 | $234K | Hold |
6,287
| – | – | 0.08% | 46 |
|
|
2019
Q3 | $214K | Sell |
6,287
-127
| -2% | -$4.62K | 0.08% | 49 |
|
|
2019
Q2 | $264K | Hold |
6,414
| – | – | 0.1% | 37 |
|
|
2019
Q1 | $258K | Sell |
6,414
-6,524
| -50% | -$261K | 0.1% | 36 |
|
|
2018
Q4 | $536K | Buy |
12,938
+6,524
| +102% | +$271K | 0.33% | 23 |
|
|
2018
Q3 | $268K | Hold |
6,414
| – | – | 0.1% | 37 |
|
|
2018
Q2 | $221K | Buy |
6,414
+2,108
| +49% | +$72K | 0.09% | 41 |
|
|
2018
Q1 | $145K | Sell |
4,306
-462
| -10% | -$15.9K | 0.08% | 52 |
|
|
2017
Q4 | $163K | Hold |
4,768
| – | – | 0.07% | 44 |
|
|
2017
Q3 | $161K | Hold |
4,768
| – | – | 0.07% | 45 |
|
|
2017
Q2 | $151K | Hold |
4,768
| – | – | 0.07% | 50 |
|
|
2017
Q1 | $154K | Hold |
4,768
| – | – | 0.08% | 48 |
|
|
2016
Q4 | $146K | Hold |
4,768
| – | – | 0.08% | 48 |
|
|
2016
Q3 | $153K | Sell |
4,768
-1,047
| -18% | -$35K | 0.08% | 46 |
|
|
2016
Q2 | $193K | Buy |
5,815
+1,047
| +22% | +$33.4K | 0.1% | 41 |
|
|
2016
Q1 | $134K | Hold |
4,768
| – | – | 0.07% | 47 |
|
|
2015
Q4 | $146K | Hold |
4,768
| – | – | 0.07% | 46 |
|
|
2015
Q3 | $142K | Hold |
4,768
| – | – | 0.1% | 44 |
|
|
2015
Q2 | $151K | Hold |
4,768
| – | – | 0.07% | 45 |
|
|
2015
Q1 | $157K | Hold |
4,768
| – | – | 0.07% | 42 |
|
|
2014
Q4 | $141K | Hold |
4,768
| – | – | 0.08% | 46 |
|
|
2014
Q3 | $133K | Hold |
4,768
| – | – | 0.09% | 43 |
|
|
2014
Q2 | $134K | Hold |
4,768
| – | – | 0.09% | 45 |
|
|
2014
Q1 | $145K | Hold |
4,768
| – | – | 0.1% | 46 |
|
|
2013
Q4 | $139K | Buy |
4,768
+190
| +4% | +$5.53K | 0.09% | 40 |
|
|
2013
Q3 | $125K | Buy |
4,578
+211
| +5% | +$5.74K | 0.08% | 44 |
|
|
2013
Q2 | $116K | Buy |
+4,367
| New | +$121K | 0.09% | 46 |
|
Other funds holding PFE
Financial Management Professionals's PFE Position: Q2 2026 in Review
Financial Management Professionals increased its Pfizer (PFE) stake by 2.3% in Q2 2026, buying an estimated $2.8K and bringing the position to 4,666 shares worth $112K. The position accounts for 0.01% of the portfolio, ranked #215.
Financial Management Professionals first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $611K in Q1 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Financial Management Professionals held 4,666 shares of Pfizer worth $112K as of Q2 2026.
- Financial Management Professionals bought 107 Pfizer shares in Q2 2026, an estimated $2.8K.
- Pfizer made up 0.01% of Financial Management Professionals's portfolio in Q2 2026, its #215 holding.
- Financial Management Professionals first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Financial Management Professionals's Pfizer position peaked at $611K in Q1 2023.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.